Skip to content

Clinical significance of T cell immunoglobulin mucin molecule 3 in blood of patients with acute decompensated heart failure

Clinical significance of T cell immunoglobulin mucin molecule 3 in blood of patients with acute decompensated heart failure

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046810
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-05-28
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure

Interventions

ADHF group:Drug therapy
Control group:None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 85 years; 2.Cardiac function grade III-IV (NYHA); 3.Symptoms and signs typical of chronic heart failure such as decreased exercise tolerance and fluid The 4.The diagnostic cut-off value of amino terminal B-type natriuretic peptide precursor (NT-probNP) was: =450ng/L; Patients aged 50-75 years >=900ng/L; >75 years old patients >=1800 ng/L; 5.Systolic or diastolic dysfunction was suggested by echocardiography.

Exclusion criteria

Exclusion criteria: 1.Severe arrhythmias affect hemodynamics; 2.Recent history of trauma and surgery; 3.Patients with autoimmune disease, malignant tumor or severe hepatorenal insufficiency; 4.Patients with pulmonary embolism, chronic obstructive pulmonary disease, cerebrovascular accident and thyroid dysfunction; 5.Restricted cardiomyopathy, hypertrophic obstructive cardiomyopathy and constrictive pericarditis; 6.Patients with incomplete clinical data; 7.Life expectancy of other serious diseases is not more than one year; 8.Unwilling to sign an informed consent form.

Design outcomes

Primary

MeasureTime frame
Rehospitalized for heart failure;Cardiac death;

Secondary

MeasureTime frame
All-cause mortality;Cardiocerebral events;

Countries

China

Contacts

Public ContactMeng Xin

Shanghai Sixth People's Hospital

571203912@qq.com+86 18017579238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026